Stay updated with breaking news from Adxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a sell rating on the stock. Ayala Pharmaceuticals Stock Up 0.9 % ADXS stock opened at $0.56 on Wednesday. Ayala Pharmaceuticals has a 12-month low of $0.50 and a 12-month […]
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report report published on Thursday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reaffirmed a neutral rating on shares of Ayala Pharmaceuticals in a research report on Thursday, November 16th. Get Our Latest Stock Report […]
By Chris Wack Immunome shares hit their 52-week high of $25.85 on Wednesday, and are now up 381% in the past 12 months. The stock closed Tuesday's session...
Research analysts at StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock. Separately, LADENBURG THALM/SH SH reissued a “neutral” rating on shares of Ayala Pharmaceuticals in a report on Thursday, November […]
By Chris Wack Immunome shares were up 16% to $19.56 after the company agreed to buy AL102 and related drug candidate AL101 from Ayala Pharmaceuticals. Ayala...